In a groundbreaking revelation, it has come to light that many cases of mental disease may be attributed to unsuspected brain allergies. This may come as a surprise to most, including medical professionals. The idea was first brought to attention by Dr. Marshall Mandell in the early 1980s when he appeared on the Phil Donahue show and showcased videos of individuals whose mental issues were either caused or exacerbated by allergen testing. He coined the term “brain allergies,” shedding light on this previously uncharted territory.
In 1982, Dr. Von Hilsheimer introduced the first End-Point-Titration allergy testing in Florida, where I had the privilege of working with him at an allergy clinic in Orlando. Together, we astonished several MD allergists by resolving cases of depression and various other conditions through allergy testing.
During my time at the clinic, I delved deep into the realm of allergies and sensitivities. To my astonishment, I stumbled upon a list of mental diseases linked to allergens that challenged my previous understanding of psychology. This list encompassed a wide range of conditions, including schizophrenia, depression, hyperactivity (ADD/ADHD), insomnia, and many more.
The Power of EEG Biofeedback: In the year 2000, while conducting a seminar in Soviet Georgia, I was introduced to the concept of EEG biofeedback therapy, specifically targeting the elevation of brain wave amplitudes just above the Alpha range, within 12-15 Hz. This discovery prompted me to revisit the list of mental diseases associated with allergens, leading me to speculate that altering these brain waves could potentially change the brain’s response to allergens.
Upon returning to the United States, I initiated the leasing of EEG biofeedback equipment for home use, a move that did not sit well with clinicians charging hefty fees for similar services. I firmly believed that this therapy was simple enough for anyone with a high school education to grasp, but it was met with resistance from the professional community.
Subliminal Messaging: A New Approach: In 2004, I had an epiphany: why not achieve the same effect of raising the SMR brain wave through subliminal messaging? I put out a call for volunteers, and over 20 individuals with conditions ranging from ADD/ADHD to depression and insomnia responded. The results were astonishing, confirming both my allergen theory and the effectiveness of subliminal messaging.
Subsequent volunteer tests have further validated the effectiveness of this therapy, now known as Neuroliminal Training, for conditions such as ADD/ADHD, depression, insomnia, autism, and epilepsy.
The Journey Continues: Our research is ongoing, and we are currently conducting tests on cases of Alzheimer’s, PTSD, OCD/anxiety, severe depression, autism, epilepsy, and even anaphylaxis. The results thus far have been promising, offering hope for individuals facing these challenges.
Dr. Bate is a retired orthomolecular psychologist who pioneered Neuroliminal Training, an accessible method for modifying brain wave amplitudes.